Menta Capital’s Idexx Laboratories IDXX Stock Holding History

Menta Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2,091	Closed	-$456K	–	620
2018 Q2	$456K	Sell	2,091 -3,040	-59%	-$626K	0.11%	361
2018 Q1	$982K	Sell	5,131 -789	-13%	-$146K	0.21%	179
2017 Q4	$926K	Buy	+5,920	New	+$932K	0.18%	205
2017 Q3	–	Sell	-11,391	Closed	-$1.84M	–	806
2017 Q2	$1.84M	Sell	11,391 -2,120	-16%	-$344K	0.22%	146
2017 Q1	$2.09M	Buy	+13,511	New	+$1.86M	0.2%	151
2016 Q4	–	Sell	-23,973	Closed	-$2.7M	–	899
2016 Q3	$2.7M	Buy	23,973 +16,520	+222%	+$1.74M	0.26%	109
2016 Q2	$692K	Sell	7,453 -7,147	-49%	-$614K	0.1%	391
2016 Q1	$1.14M	Buy	+14,600	New	+$1.05M	0.16%	168
2015 Q1	–	Sell	-7,840	Closed	-$581K	–	749
2014 Q4	$581K	Buy	+7,840	New	+$550K	0.08%	381

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Menta Capital's IDXX Position: Q3 2018 in Review

Menta Capital sold out of Idexx Laboratories (IDXX) in Q3 2018, closing a stake of 2,091 shares — an estimated $456K sold.

Menta Capital first reported a position in IDXX in Q4 2014 and held it in 9 quarters. The position peaked at $2.7M in Q3 2016. 698 funds tracked by Wall St. Rank hold IDXX as of Q3 2018.

Menta Capital reported no remaining Idexx Laboratories position as of Q3 2018 after selling out during the quarter.
Menta Capital sold 2,091 Idexx Laboratories shares in Q3 2018, an estimated $456K.
Menta Capital first reported a position in Idexx Laboratories in Q4 2014 and held it in 9 quarters.
Menta Capital's Idexx Laboratories position peaked at $2.7M in Q3 2016.
698 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2018.

Based on Menta Capital's 13F filing for Q3 2018, filed 14 Nov 2018.